◆英語タイトル：Immunovia AB (IMMNOV) - Financial and Strategic SWOT Analysis Review
◆産業分野：Pharmaceuticals and Healthcare
Immunovia AB (Immunovia) is a molecular diagnostics company that offers clinical testing for early diagnosis of pancreatic cancer. The company develops IMMray, a technology platform based on antibody microarray analysis, which can be used in the early diagnosis of cancer, predicting disease progression, and monitoring the therapeutic responsiveness of cancers. Immunovia’s IMMray can also be used for biomarker discovery through its discovery tool for proteome scanning. The company also provides IMMray PanCan-d, a blood-based test for the detection of pancreatic cancer. Its therapeutic areas include cancer and autoimmune diseases such as systemic lupus erythematosus. The company collaborates with various cancer centers for conducting clinical evidence studies. Immunovia is headquartered in Lund, Sweden.
Immunovia AB Key Recent Developments
Mar 29,2021: Immunovia reports positive results of the blinded clinical validation of IMMray™ PanCan-d blood test in USA
Feb 11,2021: Invitation to presentation of Immunovia’s Full Year Report 2020 on February 17, 2021
Feb 10,2021: Immunovia On Track For IMMray PanCan-d Sales Start In Q1 2021
Nov 13,2020: Immunovia reports third quarter interim report January – September 2020
Sep 02,2020: Immunovia announces management team changes
This comprehensive SWOT profile of Immunovia AB provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Immunovia AB including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).
The profile contains critical company information including*,
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Note*: Some sections may be missing if data is unavailable for the company.
Key benefits of buying this profile include,
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Table of Contents
Section 1 – About the Company
Immunovia AB – Key Information
Immunovia AB – Overview
Immunovia AB – Key Employees
Immunovia AB – Key Employee Biographies
Immunovia AB – Key Operational Heads
Immunovia AB – Major Products and Services
Immunovia AB – History
Immunovia AB – Company Statement
Immunovia AB – Locations And Subsidiaries
Other Locations & Subsidiaries
Section 2 – Company Analysis
Immunovia AB – Business Description
Immunovia AB – Corporate Strategy
Immunovia AB – SWOT Analysis
SWOT Analysis – Overview
Immunovia AB – Strengths
Immunovia AB – Weaknesses
Immunovia AB – Opportunities
Immunovia AB – Threats
Immunovia AB – Key Competitors
Section 3 – Company Financial Performance Charts
Immunovia AB – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Appendix
Note*: Some sections may be missing if data is unavailable for the company
List of Tables
Immunovia AB, Key Information
Immunovia AB, Key Ratios
Immunovia AB, Share Data
Immunovia AB, Major Products and Services
Immunovia AB, History
Immunovia AB, Key Employees
Immunovia AB, Key Employee Biographies
Immunovia AB, Key Operational Heads
Immunovia AB, Other Locations
Immunovia AB, Subsidiaries
Immunovia AB, Key Competitors
Immunovia AB, SWOT Analysis
Immunovia AB, Ratios based on current share price
Immunovia AB, Annual Ratios
Immunovia AB, Interim Ratios
Capital Market Ratios